Cornerstone Advisors LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 22.2% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 54,303 shares of the healthcare conglomerate’s stock after selling 15,500 shares during the period. UnitedHealth Group accounts for about 1.3% of Cornerstone Advisors LLC’s portfolio, making the stock its 12th largest position. Cornerstone Advisors LLC’s holdings in UnitedHealth Group were worth $27,379,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Kraft Davis & Associates LLC grew its stake in shares of UnitedHealth Group by 3.4% in the 3rd quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after buying an additional 19 shares in the last quarter. Secure Asset Management LLC boosted its stake in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after purchasing an additional 19 shares during the period. Iron Horse Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after purchasing an additional 19 shares during the period. Bensler LLC boosted its stake in shares of UnitedHealth Group by 0.3% during the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after purchasing an additional 19 shares during the period. Finally, Addison Advisors LLC boosted its stake in shares of UnitedHealth Group by 9.0% during the 2nd quarter. Addison Advisors LLC now owns 241 shares of the healthcare conglomerate’s stock worth $116,000 after purchasing an additional 20 shares during the period. 85.69% of the stock is currently owned by institutional investors.
UnitedHealth Group Stock Down 0.4 %
Shares of NYSE UNH traded down $2.31 during mid-day trading on Monday, reaching $515.91. The company had a trading volume of 1,212,824 shares, compared to its average volume of 4,234,304. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $554.70. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.80 and a current ratio of 0.79. The stock has a market capitalization of $477.18 billion, a PE ratio of 21.74, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54. The stock’s 50 day moving average is $525.36 and its 200-day moving average is $517.84.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, Director Stephen J. Hemsley sold 66,081 shares of the company’s stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the completion of the sale, the director now directly owns 635,528 shares in the company, valued at $349,788,255.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.35% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts have issued reports on UNH shares. Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday. Piper Sandler reduced their price target on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. Royal Bank of Canada reiterated an “outperform” rating and set a $596.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, January 16th. HSBC reiterated a “reduce” rating and set a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Finally, UBS Group upgraded shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $520.00 to $640.00 in a research note on Monday, October 16th. One research analyst has rated the stock with a sell rating, one has given a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $575.79.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- Financial Services Stocks Investing
- 3 attractive stocks that insiders are buying
- Investing in Travel Stocks Benefits
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- How to Find Cloud Software Company Stocks to Trade and Invest
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.